Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Hazard Rate01:11

Hazard Rate

The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mapping of validated apathy scales onto the apathy diagnostic criteria for neurocognitive disorders.

International psychogeriatrics·2025
Same author

Burden of Illness in People with Alzheimer's Disease: A Systematic Review of Epidemiology, Comorbidities and Mortality.

The journal of prevention of Alzheimer's disease·2024
Same author

Lower serum osteocalcin concentrations in patients with type 2 diabetes and relationships with vascular risk factors among patients with coronary artery disease.

Journal of diabetes and its complications·2019
Same author

Is it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 international consensus group.

European psychiatry : the journal of the Association of European Psychiatrists·2018
Same author

Respiratory syncytial virus prophylaxis in cystic fibrosis: the Canadian registry of palivizumab data (2005-2016).

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2018
Same author

Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies.

Acta psychiatrica Scandinavica·2017

Related Experiment Video

Updated: Jun 25, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Computer-assisted evaluation of adverse events using a Bayesian approach

K L Lanctôt1, C A Naranjo

  • 1Clinical Pharmacology and Pharmacotherapy Research Unit, University of Toronto, Canada.

Journal of Clinical Pharmacology
|February 1, 1994
PubMed
Summary

This article introduces a new computer program designed to help healthcare providers determine if a skin reaction was caused by a medication or other factors. By using a structured question-and-answer format, the tool simplifies the complex process of identifying drug-related side effects. The authors demonstrate that such digital aids can effectively assist in clinical decision-making. Future use of these programs may lead to more accurate reporting and understanding of drug safety.

Keywords:
drug safety monitoringcausality assessmentdiagnostic softwarepharmacovigilance tools

Frequently Asked Questions

More Related Videos

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

A Computer-Based Platform for Aiding Clinicians in Eating Disorder Analysis and Diagnosis
04:19

A Computer-Based Platform for Aiding Clinicians in Eating Disorder Analysis and Diagnosis

Published on: May 10, 2022

Related Experiment Videos

Last Updated: Jun 25, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

A Computer-Based Platform for Aiding Clinicians in Eating Disorder Analysis and Diagnosis
04:19

A Computer-Based Platform for Aiding Clinicians in Eating Disorder Analysis and Diagnosis

Published on: May 10, 2022

Area of Science:

  • Pharmacovigilance research within clinical pharmacology
  • Bayesian assessment of adverse drug events methodologies

Background:

Determining the origins of idiosyncratic side effects remains a challenging task for clinicians. Many potential triggers, including both pharmaceutical and environmental factors, complicate the diagnostic process. Prior research has shown that manual causality assessments are often inconsistent and time-consuming. This uncertainty drove the need for standardized digital tools to assist medical professionals. No prior work had resolved the difficulty of integrating complex probability calculations into routine practice. Existing methods often lack the accessibility required for widespread adoption in busy clinical settings. That gap motivated the creation of automated systems to streamline these evaluations. This paper addresses the requirement for user-friendly interfaces in diagnostic software.

Purpose Of The Study:

The aim of this study is to introduce a new computerized diagnostic aid for evaluating adverse drug events. The researchers sought to address the complexity inherent in identifying the causes of idiosyncratic reactions. Many potential drug and non-drug triggers often make differential diagnosis difficult for clinicians. This project was motivated by the need for more efficient and standardized assessment methods. The authors aimed to create a user-friendly tool that simplifies the evaluation process. They focused on developing a system that utilizes Bayesian probability to improve diagnostic accuracy. This effort addresses the gap in accessible digital support for healthcare providers. The team intended to demonstrate that such technology is both practical and effective for clinical use.

Main Methods:

Review Approach framing involves the systematic development of a specialized diagnostic software application. The team designed a user-friendly interface to facilitate complex probability-based reasoning. They implemented a question-and-answer module to guide clinicians through the diagnostic workflow. This approach focuses on cutaneous manifestations suspected of being medication-related. The researchers integrated statistical algorithms to handle multiple potential triggers simultaneously. They prioritized simplicity to ensure the tool remains accessible for non-specialist practitioners. The design phase emphasized the translation of theoretical causality models into a functional digital format. This methodology ensures that the software provides actionable insights during routine patient evaluations.

Main Results:

Key Findings From the Literature indicate that the developed software successfully performs differential diagnoses for skin reactions. The authors report that their program effectively distinguishes between pharmaceutical and non-pharmaceutical causes. Their results confirm that a valid, simple, and intuitive computerized procedure is achievable. The study demonstrates that the tool reliably assists in identifying suspected drug-induced events. The researchers observed that the system handles the complexity of multiple potential triggers with high efficiency. Their findings show that the software meets the criteria for both usability and diagnostic accuracy. The data suggest that the program provides a robust framework for evaluating adverse events. These results validate the potential for digital tools to replace or augment traditional, manual assessment methods.

Conclusions:

The authors demonstrate that creating a valid and accessible digital tool for causality assessment is achievable. Their work confirms that computerized procedures can effectively support the identification of drug-induced skin conditions. The researchers propose that continued refinement of such software will enhance clinical safety protocols. Synthesis and implications suggest that digital aids reduce the complexity inherent in differential diagnosis. These findings indicate that structured questioning improves the reliability of adverse event reporting. The team highlights that ongoing implementation of these programs supports better patient monitoring. Their analysis suggests that automated systems provide a practical solution for busy healthcare environments. Future efforts should focus on expanding the application of these diagnostic aids across various medical specialties.

The program utilizes a Bayesian framework to perform differential diagnoses. By processing user-provided information through a structured question-and-answer interface, the software calculates the likelihood that a specific medication caused a cutaneous reaction compared to alternative non-drug triggers.

The tool is named MacBARDI-Q&A. It functions as a diagnostic aid designed to simplify the assessment of suspected drug-induced skin reactions by guiding clinicians through a series of logical queries.

A structured question-and-answer format is necessary to gather relevant clinical data. This approach allows the software to systematically evaluate potential causes, ensuring that the Bayesian probability calculations are based on consistent and comprehensive patient information.

The software relies on clinical data provided by the user regarding the patient's history and the nature of the skin reaction. This information serves as the input for the Bayesian algorithm to weigh drug-related versus non-drug-related causes.

The researchers measure the validity and usability of the software in a clinical context. They observe that the program successfully facilitates a differential diagnosis, confirming that a simple, computer-assisted procedure for identifying adverse events is feasible.

The authors propose that the continued development and application of such programs will improve the evaluation of putative adverse drug reactions. They suggest that these digital aids are vital for enhancing the accuracy of causality assessments in clinical practice.